Evidence map›Paper›PMID 41752408›Full record

ArticleMolecules (Basel, Switzerland)2026

Actinolactomycin from

Bang Gong, Jian Pan, Jun Zhang, Shujuan Ren, Yingnan Tang, Lin Jiang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bang GongCollege of Pharmacy, Hunan Vocational College of Science and Technology, Changsha 410004, China.
Jian PanCollege of Pharmacy, Hunan Vocational College of Science and Technology, Changsha 410004, China.
Jun ZhangCollege of Pharmacy, Hunan Vocational College of Science and Technology, Changsha 410004, China.
Shujuan RenCollege of Pharmacy, Hunan Vocational College of Science and Technology, Changsha 410004, China.
Yingnan TangCollege of Pharmacy, Hunan Vocational College of Science and Technology, Changsha 410004, China.
Lin JiangXiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China.

Funding

the Hunan Provincial Department of Education Science Research Project 22B0396the Hunan Provincial Department of Education Science Research Project 23B0988the "Liu Liang Academician Workstation" Mentorship Program 24YS004the Natural Science Foundation of Hunan Province 2025JJ80302
6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited targeted therapies, underscoring an urgent need for novel agents. The soil-derived

Indexed as

Antineoplastic AgentsStreptomycesTriple Negative Breast NeoplasmsBiological ProductsCell Line, TumorGenisteinHumansIsoflavonesMDA-MB-231 CellsAntineoplastic AgentsBiological ProductsdaidzeinGenisteinIsoflavonesactinolactomycinlead compoundnatural productsStreptomyces sp. CB00271triple-negative breast cancer

Identifiers

PMID41752408
PMCPMC12943242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.